Breast Cancer Profiling Project, Drug Sensitivity phase I: Fixed-cell GR measures of 35 breast cell lines to 34 small molecule perturbagens from library plate I. Dataset 1 of 2: Normalized growth rate inhibition values - Dataset (ID:20343)

Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Primary Target Pathway Mean Normalized Growth Rate Inhibition Value Increased Fraction Dead
BT-20 Cisplatin
0.1
Chemo
Chemotherapy
0.9474 0.00664
BT-20 Cisplatin
0.31623
Chemo
Chemotherapy
0.7633 0.01654
BT-20 Cisplatin
3.1623
Chemo
Chemotherapy
0.0662 0.10679
BT-20 Cisplatin
10.0
Chemo
Chemotherapy
-0.3367 0.52833
BT-20 Doxorubicin
0.01
Chemo
Chemotherapy
0.4333 0.12869
BT-20 Doxorubicin
0.031623
Chemo
Chemotherapy
-0.1440 0.31126
BT-20 Doxorubicin
0.31623
Chemo
Chemotherapy
-0.3158 0.50771
BT-20 Doxorubicin
1.0
Chemo
Chemotherapy
-0.4813 0.65568
BT-20 Taxol
0.00031623
Chemo
Chemotherapy
1.0128 0.00568
BT-20 Taxol
0.001
Chemo
Chemotherapy
0.8429 0.05831
BT-20 Taxol
0.01
Chemo
Chemotherapy
-0.4404 0.67612
BT-20 Taxol
0.031623
Chemo
Chemotherapy
-0.5117 0.70834
BT-20 Abemaciclib
0.001
CDK4/6
Cell cycle
0.9370 -0.00149
BT-20 Abemaciclib
0.0031623
CDK4/6
Cell cycle
0.8833 -0.00527
BT-20 Abemaciclib
0.031623
CDK4/6
Cell cycle
0.4936 -0.00426
BT-20 Abemaciclib
0.1
CDK4/6
Cell cycle
0.3565 0.00950
BT-20 Abemaciclib
3.1623
CDK4/6
Cell cycle
0.1622 0.01068
BT-20 Abemaciclib
10.0
CDK4/6
Cell cycle
-0.2160 0.37259
BT-20 Palbociclib
0.001
CDK4/6
Cell cycle
1.0987 -0.00539
BT-20 Palbociclib
0.0031623
CDK4/6
Cell cycle
0.9966 0.00011
BT-20 Palbociclib
0.31623
CDK4/6
Cell cycle
0.2359 0.04751
BT-20 Palbociclib
1.0
CDK4/6
Cell cycle
0.2044 0.04646
BT-20 AZD7762
0.001
CHK1/2
Cell cycle
1.1198 -0.00253
BT-20 Topotecan
0.01
Topo I
Chemotherapy
0.5944 0.03501
BT-20 Topotecan
0.0033333
Topo I
Chemotherapy
0.8298 0.01267